monotherapy question, did appetite move for you without a GLP-1 alongside
#cagrilintide 2024-12-03
Tuesday13 messages4 participantstimes are UTC
Highlights from this day
- VialBot — Assay note: QSC lot B-0114 reported at 99.4% of label content. 14:48
- taper_tess — changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing 15:32
- never_for_sale — if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way, your mileage will differ 16:09
Assay note: QSC lot B-0114 reported at 99.4% of label content.
✅1
did anyone find monotherapy underwhelming
added it to an existing tirzepatide dose rather than starting both, which made attribution possible
stopped for 17 months and the fullness went within a fortnight of the last dose
changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing
amylin not glp-1
❤️17😂12
is 2.4 the number for this too or am i confusing compounds
different not less
⚠️4👍11
you cannot tell which of the two is doing what in a combination and i stopped pretending i could
i titrated over twice as many weeks as i did on semaglutide and that was right for me
if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way, your mileage will differ
🙏9
monotherapy was underwhelming for me and i say that as someone who wanted it to work